Funder: National Institutes of Health
Due Dates: June 16, 2025 | October 16, 2025 | June 16, 2026 | October 16, 2026 (Letters of intent due 30 days prior to each deadline)
Funding Amounts: Up to $275,000 direct costs over 2 years; no more than $200,000 in any single year; project period max 2 years.
Summary: Supports exploratory research on mechanisms, biomarkers, and functional outcomes of trained immunity in mammalian systems, including relevance to immune development, vaccination, and immune-mediated diseases.
Key Information: Clinical trials are not allowed; applications focused solely on adaptive immunity, HIV/AIDS, or non-mammalian models are not responsive.